Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VIK develops marine phospholipid-based nutritional supplements—primarily pure Antarctic krill oil—and reduced coenzyme products for cardiovascular, cognitive, ocular, dermatological and joint health. Its flagship product has received multiple international certifications for purity and quality. The company leverages global R&D resources and advanced extraction technologies to deliver high-quality medical-grade nutrition solutions.
Clinical results per se are not applicable as these are not pharmaceutical drugs but rather certified dietary supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VIK.